跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERTAPENEM MEVON POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
ERTAPENEM MEVON POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/VIAL
Approved
THERAPEUTIC
ERTAPENEM MEVON POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/VIAL
ACS DOBFAR S.P.A. (DP INTERMEDIATE) - ITALYACS DOBFAR S.P.A. (PRIMARY AND SECONDARY PACKAGER) (ITALY)
🇸🇬 Health Sciences Authority
Approval Date
Dec 19, 2018
Approval ID
6e45318ca6745136
Company
ACS DOBFAR S.P.A. (DP INTERMEDIATE) - ITALYACS DOBFAR S.P.A. (PRIMARY AND SECONDARY PACKAGER) (ITALY)
Type
Therapeutic
Approval Details
Approval Id
6e45318ca6745136
Drug Name
ERTAPENEM MEVON POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/VIAL
Product Name
ERTAPENEM MEVON POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/VIAL
Approval Number
SIN15602P
Approval Date
2018-12-19
Registrant
NOVEM PHARMA PRIVATE LIMITED
Licence Holder
NOVEM PHARMA PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01DH03
Atc Item Name
ertapenem
Pharma Manufacturer Name
NOVEM PHARMA PRIVATE LIMITED
Active Ingredients
ertapenem sodium 1.046 g eqv to ertapenem
1 g
ertapenem sodium 1.046 g eqv to ertapenem
1 g
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 19, 2018
Approval ID
6e45318ca6745136
Type
Therapeutic
Back to HSA Approvals